BioTrack Capital

Guangzhou Reforgene Technology Co., Ltd. is a biomedical company focused on developing curative drugs for serious diseases, including genetic disorders and cancer. Established in 2019 and headquartered in Guangzhou, China, the company utilizes advanced gene editing, RNA technology, and its proprietary TIPBIG technology to create innovative therapeutic solutions. Reforgene's research targets conditions such as Thalassemia and malignant tumors, aiming to provide patients with more effective and potentially curative treatment options. Through its commitment to genomic technology, Reforgene seeks to address unmet medical needs and improve patient outcomes.

Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.

hanghai BangBang Robot Co., Ltd. is a hi-tech modernized company integrating independent research and development, production and sales of intelligent assistant products. The company was founded in 2016 and is based in Shanghai, China.

NuProbe, Inc. is an early-stage molecular diagnostics company that focuses on noninvasive nucleic acid profiling and diagnostics. Founded in 2016 and based in Cambridge, Massachusetts, with an additional office in Shanghai, China, the company has developed a unique platform utilizing genetic toehold probes for quantitative PCR (qPCR) mutation detection. This innovative probe technology offers a Sample-In Answer-Out (SIAO) solution that integrates cell-free DNA extraction, qPCR analysis, sequencing, and bioinformatics interpretations, streamlining the diagnostic process.

Rijing Biosciences has launched thyroid biopsy needles, multi-gene qPCR detection and NGS detection, Thyroscan® thyroid nodule benign and malignant classifier, and targeted surgery for thyroid cancer from preoperative sampling, diagnosis, to postoperative monitoring. Full-process series products such as post-recurrence monitoring provide a variety of solutions for the entire thyroid cancer diagnosis and treatment cycle.

Hesguard is a medical device developer and producer of high-end implantable medical devices related to ophthalmic diseases.

Yuanjian Youke is an integrated CDMO service provider for cell and gene therapy industry.

Move Vision Technology is a digital therapy and smart wearable device platform company. The company focuses on the full-cycle health management of cardiovascular diseases. As a technologically innovative enterprise in the field of cardiovascular health for life monitoring and digital therapy, the goal is to apply digital therapy in-depth in the early warning, monitoring and rehabilitation management of cardiovascular diseases. Through the interdisciplinary combination of clinical medicine, biomedical engineering, bioinformatics, etc., the research and development of multi-field software and hardware products will be completed.

Carcell Biopharma is a pre-clinical biotechnology company that specializes in the development of advanced cell and gene therapy products. The company focuses on creating biopharmaceutical platforms that utilize engineered red blood cells for immune regulation and non-viral vector gene delivery through lipid nanoparticles. By employing an innovative cross-border business model, Carcell Biopharma aims to accelerate the discovery and development of next-generation therapies in this rapidly evolving field.

Brise Pharma operates in the scientific research and technical service industry.

Guangzhou Reforgene Technology Co., Ltd. is a biomedical company focused on developing curative drugs for serious diseases, including genetic disorders and cancer. Established in 2019 and headquartered in Guangzhou, China, the company utilizes advanced gene editing, RNA technology, and its proprietary TIPBIG technology to create innovative therapeutic solutions. Reforgene's research targets conditions such as Thalassemia and malignant tumors, aiming to provide patients with more effective and potentially curative treatment options. Through its commitment to genomic technology, Reforgene seeks to address unmet medical needs and improve patient outcomes.

CytoLynx Therapeutics is a R&D and commercial platform leveraging Cytovia’s unique technologies and product pipeline.

HC Scientific Technology Co., Ltd. is a company based in Chengdu, China, that specializes in the development, manufacturing, and distribution of genetic testing instruments, reagents, and software. Founded in 2015, the company serves various sectors, including clinical molecular diagnostics, health genetic testing, and agricultural molecular breeding, both domestically and internationally. HC Scientific's product lineup features instruments such as the Matrix Arrayer for reaction plate preparation, the Matrix Cycler for thermal cycling, and the Matrix Scanner for fluorescence detection. Additionally, the company provides consumables like the Matrix plate and Matrix Mix genotyping reagents, along with a data management system known as Matrix Master. Committed to innovation, HC Scientific focuses on autonomous research and development of its intellectual property, aiming to deliver high-throughput, automated, and cost-effective genetic testing solutions.

Tendfo is a company focused on the development and manufacturing of advanced medical devices specifically designed for interventional therapy related to pulmonary embolism. The organization is dedicated to research and development, as well as the production and sale of high-quality medical devices aimed at venous vascular intervention. Tendfo offers its products at competitive prices while also providing technical consultation, technology transfer, and related services in the medical device sector. Additionally, the company is involved in the import and export of medical devices and technologies, contributing to the advancement of interventional medical solutions.

Chengdu Qitan Technology Co., Ltd. specializes in the development and manufacture of advanced gene sequencing instruments utilizing nanopore technology. Founded in 2016 and based in Chengdu, China, the company offers a fourth generation gene sequencer that enables single-molecule sequencing with long read lengths and real-time output. This innovative technology is designed to serve various sectors, including biopharmaceuticals, healthcare, and agriculture, facilitating applications such as immunophenotyping, pathogen detection, analysis of intestinal flora, and tumor genome detection. Qitan Tech's solutions are notable for their cost-effectiveness and simplicity, as they do not require complicated library preparation, thus enhancing the accessibility of gene sequencing for cutting-edge biological research and clinical diagnostics.

Innogen Pharmaceutical Technology is an international biopharmaceutical company specializing in the development and manufacturing of innovative drugs. The company utilizes advanced genetic engineering and recombinant protein biopharmaceutical processes to create new therapies. Its primary focus is on addressing the treatment needs of patients suffering from diabetic metabolic diseases and significant central nervous system disorders. Through its research and development efforts, Innogen aims to deliver effective solutions that enhance patient care and improve health outcomes.

EdiGene is dedicated to the development of genome editing technology for human health. Genome editing technology enables the targeted modification of genetic information in human cells, including gene knockout, knock-in and targeted mutations. They aim at providing the high quality products and services for the patients, the pharmaceutical industry, and the scientific research community with the most advanced genome editing technology.EdiGene innovates and applies genome editing technology to developing human therapeutic products. Their therapeutic approach is to treat diseases at the molecular level, making gene therapy safer and more effective.

Brattea is a medical device research and development company specializing in renal denervation products aimed at treating conditions such as hypertension, cancer pain, and diabetes. The company develops interventional devices, including renal artery ablation catheters and radiofrequency ablation equipment, as well as medical mapping systems. These products are designed to address a range of health issues, including refractory hypertension, obstructive sleep apnea, kidney disease, and heart failure. Brattea is committed to providing reliable medical solutions that enhance patient care and improve health outcomes.

OnQuality Pharmaceuticals offers trials to assess the safety and efficacy of a targeted supportive care agent that addresses the specific side effects of vascular endothelial growth factor receptor (VEGFR) inhibitors among cancer patients.

NewMed Medical Co., Ltd. is a Shanghai-based company focused on the research, development, manufacture, and marketing of interventional artificial heart valve systems. Established in 2015, the company specializes in producing artificial heart valves and transcather implantation systems designed to replace diseased mitral valves. These innovative products aim to simplify heart valve replacement surgery, thereby reducing treatment risks and facilitating quicker patient recovery while also lowering surgical costs. Through its advancements in medical technology, NewMed Medical contributes to improved outcomes in cardiac care.

Hengmei Foods is a group of companies that focuses on the R&D and production of healthy food, snacks, and weight management.

Shanghai MediTrust Health Technology Co., Ltd. provides help to patients solve its medical expenses through financial insurance. The firm is based in Shanghai, China.

Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.

NuProbe, Inc. is an early-stage molecular diagnostics company that focuses on noninvasive nucleic acid profiling and diagnostics. Founded in 2016 and based in Cambridge, Massachusetts, with an additional office in Shanghai, China, the company has developed a unique platform utilizing genetic toehold probes for quantitative PCR (qPCR) mutation detection. This innovative probe technology offers a Sample-In Answer-Out (SIAO) solution that integrates cell-free DNA extraction, qPCR analysis, sequencing, and bioinformatics interpretations, streamlining the diagnostic process.

SeekGene specializes in genetic data analysis solutions, particularly in the development and clinical application of single-cell sorting assays. The company leverages its extensive research and clinical service experience to advance single-cell sequencing technology for real-world clinical research. SeekGene has developed a high-throughput single-cell transcriptome sequencing kit that is recognized for its superior performance, flexibility, and cost-effectiveness. This technology aims to facilitate the clinical transformation of single-cell sequencing, enabling better understanding of immune responses at the single-cell level. Additionally, SeekGene focuses on T cell receptor and peptide-bound major histocompatibility complex pairing technologies, which are essential for clinical and drug research, as well as for monitoring and treating various diseases.

CF PharmTech, Inc. develops and manufactures inhalation products. The company’s products include metered dose inhaler (MDI), dry powder inhalers (DPI), nasal sprays, nebulizer, and respiratory medicines. It provides contract manufacturing organization (CMO) services. It conducts research and development in the areas of asthma, chronic obstructive pulmonary disease (COPD), and rhinitis. The company was founded in 2007 and is based in Suzhou, China.

Asieris Pharmaceuticals Co. Ltd. is a Chinese biotechnology company established in 2010 and headquartered in Taizhou, China. The company specializes in the research and development of pharmaceutical products aimed at treating tumors and addressing multidrug-resistant infections. Asieris focuses on innovative therapies within the oncology sector and is dedicated to combating the challenges posed by drug-resistant pathogens.

Ezisurg Medical Co., Ltd. is a company based in Shanghai, China, focused on the development and commercialization of minimally invasive surgical products. Established in 2011, it specializes in devices for various medical procedures, including general, bariatric, thoracic, and colorectal surgeries. The company's product lineup includes the easyEndo Universal Linear Cutting Stapler, easyCS Circular Stapler, easyLC Linear Cutter Stapler, easyPPH Stapler, and easyUS Ultrasonic Scalpel System. Ezisurg Medical aims to provide high-quality, cost-effective surgical solutions to hospitals, surgeons, and patients, thereby enhancing the efficacy and safety of minimally invasive surgical treatments.

OnQuality Pharmaceuticals offers trials to assess the safety and efficacy of a targeted supportive care agent that addresses the specific side effects of vascular endothelial growth factor receptor (VEGFR) inhibitors among cancer patients.

QnQuality Pharmaceuticals is a new drug research and development specialist for cancer-assisted therapeutics, focusing on unmet clinical needs in the field of oncology supportive care, and is committed to helping cancer patients around the world improve their quality of life. Kuankuo Pharmaceutical has established a rich R&D pipeline covering six indications and a research and development team in China and the United States (

Hangzhou Yunhu Technology Group Co.,Ltd develops an Internet platform for primary medical services in China. It offers a series of platform-based testing products; and a SaaS based LIS\HIS platform, designed for local medication institutions. It also provides a third party cold chain logistic services to support the blood and drug delivery. The company was founded in 2017 and is based in Hangzhou, China.

AccuMedical is a full-line product company in the field of neurological intervention, headquartered in Beijing with an R&D center located in California. It develops and produces medical device products for the treatment of aneurysms, preventing, and treating bleeding diseases caused by the rupture of vascular aneurysms.

Shanghai MediTrust Health Technology Co., Ltd. provides help to patients solve its medical expenses through financial insurance. The firm is based in Shanghai, China.

Hangzhou Yunhu Technology Group Co.,Ltd develops an Internet platform for primary medical services in China. It offers a series of platform-based testing products; and a SaaS based LIS\HIS platform, designed for local medication institutions. It also provides a third party cold chain logistic services to support the blood and drug delivery. The company was founded in 2017 and is based in Hangzhou, China.

HaiHe Biopharma is a developer of innovative anti tumor drugs designed to overcome complex diseases and improve pharmacological evaluation. The company focuses on discovery, development and commercialization of innovative anti-tumor drugs, pharmacological efficacy evaluation and provide products including novel topoisomerase I inhibitors and oral c-Met highly selective inhibitors, enabling customers to improve their health conditions and research quality in an efficient manner.

Hangzhou Yunhu Technology Group Co.,Ltd develops an Internet platform for primary medical services in China. It offers a series of platform-based testing products; and a SaaS based LIS\HIS platform, designed for local medication institutions. It also provides a third party cold chain logistic services to support the blood and drug delivery. The company was founded in 2017 and is based in Hangzhou, China.

Yuchen Guangyi is a high-tech enterprise integrating research, development, production and sales of a new biomedical system.

HC Scientific Technology Co., Ltd. is a company based in Chengdu, China, that specializes in the development, manufacturing, and distribution of genetic testing instruments, reagents, and software. Founded in 2015, the company serves various sectors, including clinical molecular diagnostics, health genetic testing, and agricultural molecular breeding, both domestically and internationally. HC Scientific's product lineup features instruments such as the Matrix Arrayer for reaction plate preparation, the Matrix Cycler for thermal cycling, and the Matrix Scanner for fluorescence detection. Additionally, the company provides consumables like the Matrix plate and Matrix Mix genotyping reagents, along with a data management system known as Matrix Master. Committed to innovation, HC Scientific focuses on autonomous research and development of its intellectual property, aiming to deliver high-throughput, automated, and cost-effective genetic testing solutions.